These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16523535)

  • 1. Natriuretic peptide testing in primary care.
    Murphy JJ; Fuat A
    Circulation; 2006 Mar; 113(9):f35-6. PubMed ID: 16523535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suspected heart failure: how important is the BNP-testing for the general practitioner?].
    Pfister R; Erdmann E
    MMW Fortschr Med; 2009 Apr; 151(15):31-2. PubMed ID: 19728678
    [No Abstract]   [Full Text] [Related]  

  • 3. On "Getting the right message".
    Collins SP
    Ann Emerg Med; 2007 Mar; 49(3):383-4; author reply 384. PubMed ID: 17317514
    [No Abstract]   [Full Text] [Related]  

  • 4. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients.
    Hildebrandt P; Collinson PO
    Am J Cardiol; 2008 Feb; 101(3A):25-8. PubMed ID: 18243854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
    Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
    Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
    Lamb EJ; Vickery S; Price CP
    J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 13. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
    van Kimmenade RR; Pinto Y; Januzzi JL
    Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 15. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

  • 16. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
    Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
    [No Abstract]   [Full Text] [Related]  

  • 17. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 18. Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
    Richards AM
    J Am Coll Cardiol; 2008 Sep; 52(12):1004-5. PubMed ID: 18786481
    [No Abstract]   [Full Text] [Related]  

  • 19. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
    Bayes-Genis A
    Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.